Results

Total Results: 1,558 records

Showing results for "participant".

61. Integrating stakeholder preferences in comparative effectiveness research using multi-criteria decision analysis (MCDA) and Conjoint Analysis (CA) (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/mcda-ijzerman.pdf
    January 01, 2011 - Slide 7 Conjoint analysis  Each participant receives N choice sets.

62. Methods Guide for Comparative Effectiveness Reviews_Inclusion of Nonrandomized Studies of Interventions in Systematic Reviews of Intervention Effectiveness: An Update (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/product/pdf/methods-guide-inclusion-nonrandomized-studies.pdf
    September 01, 2022 - RCTs often have narrow participant eligibility criteria that exclude some subsets of the population, … longitudinal Retrospective • May be useful for rare diseases or newer interventions • Ease of participant … They lack participant follow-up and therefore do not allow inference regarding temporality of the association … The closer to 1, the stronger the probability that the participant would be in the intervention group … ; likewise, the closer to 0, the stronger the probability the participant would be in the control group

63. Methods Guide for Comparative Effectiveness Reviews_Inclusion of Nonrandomized Studies of Interventions in Systematic Reviews of Intervention Effectiveness: An Update (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/pdf/methods-guide-inclusion-nonrandomized-studies.pdf
    September 01, 2022 - RCTs often have narrow participant eligibility criteria that exclude some subsets of the population, … longitudinal Retrospective • May be useful for rare diseases or newer interventions • Ease of participant … They lack participant follow-up and therefore do not allow inference regarding temporality of the association … The closer to 1, the stronger the probability that the participant would be in the intervention group … ; likewise, the closer to 0, the stronger the probability the participant would be in the control group

64. Version-3-Immunity-After-Covid-19-Appendix-Table-B-1 (xls file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/version-3-immunity-after-COVID-19-appendix-table-B-1.xlsx
    January 24, 2022 - Imunodiagnostic Products; developed at Centers for Disease Control Only one sample for serology per participant … who tested positive for SARS-CoV-2 infection at South West London Pathology during the study period Participant … cohort May-September 2020 to January 25, 2021 ~6.75 months (27 weeks) NR HCW & other essential workers Participant … Switzerland Data of SARS-CoV-2 infections was extracted from a centralized state registry and linked to each participant

65. Methods Future Research Needs Number 8: Framework for Considering Study Designs (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/study-design-framework_research.pdf
    March 01, 2012 - Other considerations: Meta-analysis of individual participant data Modeling Additional systematic … Additional Considerations Meta-analysis of individual participant data, modeling, and additional systematic … Meta-analysis of individual participant data (MIPD). … In a meta-analysis of individual participant data (MIPD), data from existing studies are brought together … When individual participant data are available, outcome and exposure definitions can be standardized

66. Development of Harmonized Outcome Measures for Use in Patient Registries and Clinical Practice: Methods and Lessons Learned (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/white-paper-standardized-library.pdf
    February 01, 2019 - Began discussing key participant, provider, and disease characteristics that should be collected … Continued discussion of participant, provider, and disease characteristics. … Defining Participant, Provider, and Disease Characteristics The first OMF domain describes characteristics … of the participant, disease, and provider that are important for fully defining an outcome measure … For each of the five clinical areas, the project team developed an initial list of participant, disease

67. Evidence Report on the (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/dietary-supplements_research-protocol.pdf
    December 15, 2010 - : inclusion/exclusion criteria, numbers enrolled and analyzed, participant characteristics (age, … controlled studies Uncontrolled experimental (for KQ 5 only) Selection Bias Appropriateness of participant … mode of harms collection (e.g., active or passive, standard tool) X X X aAppropriateness of participant … Methodological diversity will be explored by adequacy of participant selection, important confounding

68. Appendix-Table-B-1-Observational-Studies (xls file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/appendix-table-B-1-observational-studies.xlsx
    March 20, 2021 - Serology done using "locally validated assays" NR Possible reinfection defined as a positive cohort participant … with two PCR+ samples ≥90 days apart, or a positive cohort participant with a new PCR+ test at least

69. Fiber Intake and Laxation Outcomes (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/fiber-intake-protocol.pdf
    August 15, 2023 - allocation concealment, and outcome assessor blinding are all unclear (with the recognition that the participant … Each study will be described in summary and evidence tables presenting study design features, study participant

70. Chronic-urinary-retention-protocol (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/chronic-urinary-retention_research-protocol.pdf
    November 19, 2012 - control characteristics (intervention components, timing, frequency, duration); followup duration; participant … bias for this topic and to foster consistency with the RCT risk-of-bias instrument likely including participant

71. Registry of Patient Registries (RoPR) Policies and Procedures (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/registry-of-patient-registries_research-2012-2_1.pdf
    January 01, 2012 - • To increase awareness of the registry in order to improve investigator and, in some cases, participant … information about patient registries will be posted on the RoPR at registry inception, prior to the first participant

72. Methods-Guidance-Reporting-Bias Methods (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-guidance-reporting-bias_methods.pdf
    November 01, 2013 - biologics and devices regulated by the FDAb No later than 21 days after enrollment of first participant … sample - Participant flow - Primary and secondary outcomes - Certain agreements regarding dissemination … The RePORT database does not include variables indicating study registration or participant recruitment … FDA for trials involving investigational new drugs Study Results - Participant Flow - Baseline … Key Inclusion and Exclusion Criteria Inclusion and exclusion criteria for participant selection, including

73. Behavioral Programs for Diabetes Mellitus (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/diabetes-behavior-programs_executive.pdf
    September 11, 2015 - Achieving program acceptability as measured by participant attrition rates? Key Question 2. … effect on diabetes-related health care utilization; and (c) program acceptability as measured by participant … According to our decision rules for assessing risk of bias, a low risk of bias for participant and … Participant blinding in this manner was rarely reported. … All The risk of bias from participant and personnel blinding was high in most trials.

74. Evidence-based Practice Center Systematic Review Protocol: Therapies for Clinically Localized Prostate Cancer (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/prostate-cancer-therapies-protocol_amended110619.pdf
    November 02, 2019 - and exclusion criteria, intervention and control characteristics, sample size, follow-up duration, participant … bias of eligible RCTs will be assessed using the Cochrane Risk of Bias Tool.14 Components include participant

75. Methods Research Report: Linking Evidence Reviews to Organizational Guideline Planning: A Pilot Test of an Interactive Web-Based Presentation and Discussion of Evidence (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/linking-evidence-reviews-methods_0.pdf
    October 01, 2018 - ............................................................................................... 7 Participant … We also documented participant discussion and questions during the cyberseminar itself. … Participant Survey Results Of the nine participants surveyed, only three responded, despite receiving … Organizational Context Evaluation Results Evaluation of the Cyberseminar Evaluation of the EPC Report Participant

76. Layout 1 (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/preterm-birth-terbutaline-pump_executive.pdf
    September 01, 2011 - Nonrandomized trial 1 12 Prospective cohort 2 13,14 Retrospective cohort 7 15-21 Case series 2 22,23 Participant … and one RCT reported outcomes related to the pump device.11,22,23 In a case series of 51 women, one participant … Setting All studies were from the United States and participant data were acquired from a national database … Bias: A systematic error, arising from participant selection or outcome measurement that produces an

77. Treatment of Osteoarthritis of the Knee: An Update Review (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/osteoarthritis-knee-update-executive-170505.pdf
    May 01, 2017 - University Arthritis Index [WOMAC] pain measures), as two tools used in the same study on the same participant … We rated applicability of participant populations and interventions separately, as described below. … The most prevalent limit to study quality was participant blinding: Only 33 of 85 RCTs reported an attempt … sufficient numbers of participants to enable prespecified subgroup analysis according to important participant … of the trials included in our review modified interventions based on an assessment of individual participant

78. The Evidence-Based Care Challenge: A Case Study (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/ebc-challenge-case-130621.pdf
    June 01, 2013 - This process facilitated participant-to-participant communication, and was maintained until the close

79. autism-update-protocol-130920 (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/autism-update_research-protocol.pdf
    September 20, 2013 - able to be abstracted from data in the papers Data must be presented in the aggregate (vs. individual participant … We anticipate that these data will include those related to baseline participant characteristics (age … This quality- assessment approach considered factors related to study design, diagnostic approach, participant

80. Research Protocol: Breast Reconstruction After Mastectomy (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/breast-reconstruction-mastectomy-protocol.pdf
    April 09, 2020 - Because NRCSs, like RCTs, can be impacted by the lack of blinding and by participant loss to followup … single-group studies, we will use the items from the Cochrane Risk of Bias Tool28 that pertain to issues of participant … systematic review will be described in summary and evidence tables presenting study design features, study participant